الفهرس 
Ecttopiic pregnancy
Etiology of ectopic pregnancyOnly 14 pages are availabe for public view
 |  | from | 155 |  |  |
| | | from | 155 | | |
Abstract
Ectopic pregnancy is the implantation of a fertilized ovum outside the
endometrial cavity, occurs in approximately 1.5 to 2.0% of pregnancies and
is potentially life-threatening. EP can be diagnosed accurately at very early
stages by using transvaginal ultrasound (TVS) and sensitive plasma-human
chorionic gonadotropinserum (HCG) measurements.
Methotrexate is considered as the standard medical regimen in the
United States and Europe for early tubal EP when the patients are
hemodynamically stable women with unruptured tubal pregnancy ≤ 3.5 cm
on transvaginal U/S without fetal cardiac activity with serum hCG level
<5,000 mIU/L with the patient’s desire for future pregnancy and in the
absence of contraindications to methotrexate.
AMH is the best marker of ovarian reserve that can be tested in
follicular as well as luteal phase as it is simple, easy, non-invasive, accurate
and not affected by pregnancy or hormonal contraceptive treatment.
This study was conducted on (25) patients presented with history of
tubal pregnancy who received methotrexate as a conservative treatment and
want future pregnancy.